Neuralink Blog

Announcing Neuralink’s Patient Registry

December 17, 2022

Over the last few years, we have worked with patient advocacy groups and a consumer advisory board consisting of individuals with spinal cord injury and their caregivers to guide product development and community engagement.

As an expansion of these efforts, we’ve launched a Patient Registry to learn more about individuals who want to contribute to this initiative and who may be interested in enrolling in future Neuralink clinical trials, when they become available.

Keep Reading

Husbandry Refinement

November 30, 2022

The first episode of our Refinement Series will look at how we evaluate the well-being of an animal as it pertains to housing, food, and water - the key elements of husbandry. We share examples of how we identify gaps in our program and how we tackle those with the help and support of our engineers and animal care teams.

Keep Reading

Championing the 3 Rs

November 20, 2022

At Neuralink, we are committed to championing the “3 Rs” of research:

  • Refinement
  • Reduction
  • Replacement

In this blog post, we describe the 3 Rs and introduce our upcoming multi-part series highlighting the challenges we encounter in animal medical research. We discuss how we think about solutions to these problems using the framework of the 3 Rs. We hope you will take this opportunity to learn alongside us as we dive into the complex world of ensuring animal well-being in a research setting.

Keep Reading

Neuralink’s Commitment to Animal Welfare

February 14, 2022

Animals at Neuralink are respected and honored by our team. Without proper context, information from medical records and study data can be misleading. In this blog post, we want to provide an accurate statement of Neuralink’s commitment to animal welfare.

Keep Reading

Series C Funding Round Announcement

July 29, 2021

Neuralink Corp is pleased to announce our Series C funding round of $205 million, led by Vy Capital, with participation from Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.

Keep Reading

Pager Plays MindPong

April 18, 2021

Neuralink is developing a fully-implanted, wireless, high-channel count, brain-computer interface (BCI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease.

Keep Reading